CAS: 1489389-18-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT245737 REF: IN-DA00ABR8CAS: 1489389-18-5 | % | 98.00 €~650.00 € | Wed 04 Dec 24 |
 | CCT245737 REF: TM-T7080CAS: 1489389-18-5 | 97.06% - 99.69% | 39.00 €~541.00 € | Wed 11 Dec 24 |
 | CCT245737 REF: 3D-PJC38918CAS: 1489389-18-5 | Min. 95% | To inquire | Wed 15 Jan 25 |
Ref: IN-DA00ABR8
| 5mg | 98.00 € | ||
| 10mg | 137.00 € | ||
| 25mg | 192.00 € | ||
| 50mg | 305.00 € | ||
| 100mg | 650.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
CCT245737
CAS:1489389-18-5
CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and …
Formula:
C16H16F3N7O
Purity:
97.06% - 99.69%
Color and Shape:
Solid
Molecular weight:
379.34
Ref: TM-T7080
| 1mg | 39.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 82.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 220.00 € | ||
| 50mg | 363.00 € | ||
| 100mg | 541.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
CCT245737
CAS:1489389-18-5
CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The …
Formula:
C16H16F3N7O
Purity:
Min. 95%
Molecular weight:
379.34 g/mol
Ref: 3D-PJC38918
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
